Summary
Patients with insulin-dependent diabetes mellitus (IDDM) possess antibodies to the cytoplasmic domains of two closely related tyrosine phosphatase-like proteins, IA-2 and phogrin, previously detected as 40 kDa and 37 kDa tryptic fragments, respectively. A higher proportion of IDDM patients possess antibodies to IA-2 than to phogrin, and autoimmunity to phogrin might arise through cross-reactivity with the highly homologous IA-2. In this study, we have investigated the major regions of IA-2 recognized by antibodies in IDDM patients and examined the ability of phogrin to block antibody binding to these regions as a measure of cross-reactivity. Analysis of antibody binding to in vitro transcribed and translated polypeptides representing different regions of the cytoplasmic domain of IA-2 identified five different patterns of reactivity with antibodies in IDDM. Protein footprinting analysis, whereby polypeptide fragments generated on protease treatment of immune complexes are studied, indicated considerable heterogeneity in antibody recognition of IA-2, even between sera with similar reactivity to deletion mutants. Blocking studies with recombinant phogrin indicated that IA-2 antibodies recognize epitopes that are both unique to IA-2 and shared with phogrin. The amino-terminal 150 amino acids of the cytoplasmic domain of IA-2 encompass epitopes that are not represented on phogrin, whereas shared epitopes are localized within the carboxy-terminal 220 amino acids. The results demonstrate considerable heterogeneity between IDDM patients in autoantibody recognition of IA-2 in IDDM, whereas antibody recognition of phogrin is restricted in most patients to epitopes also present on IA-2.
Article PDF
Similar content being viewed by others
Abbreviations
- IDDM:
-
insulin-dependent diabetes mellitus
- PTP:
-
protein tyrosine phosphatase
- JM:
-
juxtamembrane
- Hepes:
-
4-(2-hydroxyethyl)-l-piperazine-ethanesulphonic acid
- IA-2ic:
-
cytoplasmic domain of IA-2
- phogrin-ic:
-
cytoplasmic domain of phogrin
References
Christie M, Vohra G, Champagne P, Daneman D, Delovitch TL (1990) Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment. J Exp Med 172: 789–794
Christie MR, Hollands JA, Brown TJ, Michelsen BK, Delovitch TL (1993) Detection of pancreatic islet 64,000 Mr autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase. J Clin Invest 92: 240–248
Christie MR, Genovese S, Cassidy D et al. (1994) Antibodies to islet 37k-antigen, but not to glutamate decarboxylase, discriminate rapid progression to insulin-dependent diabetes mellitus in endocrine autoimmunity. Diabetes 43: 1254–1259
Bingley PJ, Christie MR, Bonifacio E et al. (1994) Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43: 1304–1310
Genovese S, Bingley PJ, Bonifacio E et al. (1994) Combined analysis of IDDM-related autoantibodies in healthy schoolchildren. Lancet 344: 756
Payton MA, Hawkes CJ, Christie MR (1995) Relationship of the 37,000- and 40,000-Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 96:1506–1511
Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E (1995) Identification of protein tyrosine phosphatase-like IA-2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40 k autoantigen and a target of islet cell antibodies. J Immunol 155: 5419–5426
Passini N, Larigan JD, Genovese S, Appella E, Sinigaglia F, Rogge L (1995) The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2. Proc Natl Acad Sci 92: 9412–9416
Lu J, Li Q, Xie H et al. (1996) Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci 93: 2307–2311
Hawkes CJ, Wasmeier C, Christie MR, Hutton JC (1996) Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Diabetes 45: 1187–1192
Lampasona V, Bearzatto M, Genovese S, Bosi E, Ferrari M, Bonifacio E (1996) Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen. J Immunol 157: 2707–2711
Zhang B, Lan MS, Notkins AL (1997) Autoantibodies to IA-2 in IDDM location of major antigenic determinants. Diabetes 46: 40–43
Lan MS, Lu J, Goto Y, Notkins AL (1994) Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 13: 505–514
Wasmeier C, Hutton JC (1996) Molecular cloning of phogrin, a protein-tyrosine phosphatase homologue localized to insulin secretory granule membranes. J Biol Chem 271: 18161–18170
Barford D, Flint AJ, Tonks NK (1994) Crystal structure of human protein tyrosine phosphatase 1B. Science 263: 1397–1404
Kawasaki E, Eisenbarth GS, Wasmeier C, Hutton JC (1996) Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes: overlapping specificities to phogrin and ICA512/IA-2. Diabetes 45: 1344–1349
Christie M, Landin Olsson M, Sundkvist G, Dahlquist G, Lernmark A, Baekkeskov S (1988) Antibodies to a Mr-64000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. Diabetologia 31: 597–602
Shesberadaran H, Payne L (1988) Protein antigen-monoclonal antibody contact sites investigates by limited proteolysis of monoclonal antibody-bound antigen: protein “footprinting”. Proc Natl Acad Sci 85:1–5
Lai M, Christie M, Betterle C, Foxon R, Zanchetta R, Spadaccino A, Bottazzo GF (1997) “The UK and Padua polyendocrine prospective study”. Association of antibodies to IA-2 and phogrin and progression to IDDM. Diabetologia 40 [Suppl 1] 40:A76 (Abstract)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hatfield, E.C.I., Hawkes, C.J., Payton, M.A. et al. Cross reactivity between IA-2 and phogrin/IA-2β in binding of autoantibodies in IDDM. Diabetologia 40, 1327–1333 (1997). https://doi.org/10.1007/s001250050828
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s001250050828